Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model

Journal of Molecular Biology

Volumn 303, Issue 4, 2000, Pages 567-582

  Wang, Wei ^a   Kollman, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dimer stability; HIV protease; MM PBSA; Molecular dynamics; Virtual mutagenesis method

Indexed keywords

DIMER; MONOMER; PROTEINASE; SOLVENT; VIRUS ENZYME;

ARTICLE; BINDING AFFINITY; ENZYME INHIBITION; MOLECULAR DYNAMICS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 0034602373     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4057     Document Type: Article

References (40)

1. Computational methods to predict binding free energy in ligand-receptor complexes
2. Transdominant inhibitory human immunodeficiency virus type I protease monomers prevent protease activation and virion maturation
3. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges - The RESP model
4. Free energy via molecular simulations: Application to chemical and biochemical system
5. Normal mode analysis of protein dynamics
6. Stability and activity of human immunodeficiency virus protease - Comparison of the natural dimer with a homologous, singlechain tethered dimer
7. Flap opening in HIV-1 protease simulated by 'activated' molecular dynamics
8. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules
9. Particle Mesh Ewald - An Nlog(N) method for Ewald sums in large systems
10. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor
11. Characterization of an active single polypeptide form of the human immunodeficiency virus type-I protease
12. The MIDAS display system
13. Calculating electrostatic interactions in biomolecules: Method and error assessment
14. Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases
15. Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism
16. Kinetic studies of human immunodeficiency virus type I protease and its active site hydrogen bond mutant A285
17. Flap opening and dimer-interface flexibility in the free and inhibitor-bound HW protease, and their implications for function
18. Activity and dimerization of human immunodeficiency virus protease as a function of solvent composition and erzyme concentration
19. Comparison of simple potential functions for simulating liquid water
20. Active human immunodeficiency virus protease is required for viral infectivity
21. Free energy calculations: Applications to chemical and biochemical phenomena
22. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity
23. pK(a) shifts in small molecules and HIV protease: Electrostatics and conformation
24. Computational alanine scanning to probe protein-protein interactions: A novel approach to evaluate binding free energies
25. Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation
26. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules
27. Reaction path and free energy calculations of the transition between alternate conformations of HIV-1 protease
28. Macromolecular inhibitors of HIV-1 protease: Characterization of designed heterodimers
29. Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes
30. Reduced surface - An efficient way to compute molecular surfaces
31. Accurate calculation of hydration free energies using macroscopic solvent models
32. Ionization states of the catalytic residues in HIV-1 protease
33. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate - DNA helices
34. Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease
35. Methods for calculation of free energies and binding constants: Successes and problems
36. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272
37. Conserved folding retroviral proteases-crystal structure of a synthetic HIV-1 protease
38. NMR and X-ray evidence that the HIV protease catalytic aspartyl groups are protonated in the complex formed by the protease and a non-peptide cyclic urea-based inhibitor
39. Dissociative inhibition of dimeric enzymes - Kinetic characterization of the inhibition of HIV-1 protease by its COOH terminal tetrapeptide
40. Inclusion of solvation in ligand binding free energy calculations using the generalized Born model